Evaxion Biotech: Q1 Earnings Insights

Comments
Loading...

 

Evaxion Biotech EVAX reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Evaxion Biotech beat estimated earnings by 24.24%, reporting an EPS of $-0.25 versus an estimate of $-0.33.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 1.85% drop in the share price the next day.

 

To track all earnings releases for Evaxion Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

EVAX Logo
EVAXEvaxion Biotech AS
$1.84-3.66%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum0.55
Growth-
Quality-
Value3.65
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: